Tcr2 Therapeutics Inc (NASDAQ:TCRR) People

Tcr2 Therapeutics Inc

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stephen Webster
Other companies: Cullinan Therapeutics, Inc. (Chair of the Audit Committee · Since at least Jan 7, 2021); NextCure, Inc. (Director · Since at least May 8, 2019); Gritstone bio, Inc. (Director · Apr 26, 2024 – Apr 4, 2025 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 2, 2022 · Past); Viking Therapeutics, Inc. (Director · Apr 28, 2015 – Jan 2, 2020 · Past); Spark Therapeutics Inc (CHIEF FINANCIAL OFFICER · Jan 29, 2015 – Dec 17, 2019 · Past); Optimer Pharmaceuticals Inc (Chief Financial Officer · Jun 25, 2012 – Oct 24, 2013 · Past); Adolor Corp (SVP, Finance & CFO · Sep 9, 2010 – Dec 12, 2011 · Past)
Director · Apr 30, 2020 – Jun 1, 2023 · Past
Andrew Allen
Other companies: Cullinan Therapeutics, Inc. (Member of the Compensation Committee · Since at least Aug 7, 2025); Adaptimmune Therapeutics PLC (Director · Jun 1, 2023 – Jul 1, 2024 · Past); Gritstone bio, Inc. (PRESIDENT AND CEO, Director · Sep 27, 2018 – Jun 24, 2024 · Past); Sierra Oncology Inc (Director · Oct 23, 2017 – Jul 1, 2022 · Past); Epizyme Inc (Director · Jun 9, 2014 – Jun 11, 2021 · Past); Clovis Oncology Inc (See Remarks · Nov 15, 2011 – Mar 2, 2015 · Past); Pharmion Corp (Chief Medical Officer, EVP · Aug 31, 2006 – Mar 1, 2008 · Past)
Director · Feb 13, 2019 – Jun 1, 2023 · Past
Ansbert Gadicke
Other companies: Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Jun 22, 2022 · Past); Kalaris Therapeutics, Inc. (Director · Jul 29, 2020 – Jul 28, 2022 · Past); Iteos Therapeutics Inc (Director · Jul 23, 2020 – Jul 28, 2020 · Past); Chiasma Inc (Director · Jul 15, 2015 – Jun 9, 2016 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Mar 6, 2012 · Past); Radius Health, Inc. (Director · May 17, 2011 – Feb 17, 2017 · Past)
Director · Feb 13, 2019 – Jun 1, 2023 · Past
Garry E. Menzel
Other companies: Adaptimmune Therapeutics PLC (Non-Executive Director · Since at least Jun 1, 2023); Stoke Therapeutics, Inc. (Director · Since at least Aug 13, 2020); Black Diamond Therapeutics, Inc. (Operating Partner, GHO Capital Partners LLP · Since at least Jan 29, 2020); DaVita Inc. (Senior Vice President, Finance · Sep 9, 2013 – Sep 9, 2013 · Past); Regulus Therapeutics Inc (COO & Executive VP, Finance · Oct 4, 2012 – Dec 11, 2012 · Past)
President and CEO, Director · Feb 13, 2019 – Jun 1, 2023 · Past
Mitchell H Finer
Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – Jul 31, 2019 · Past); Bluebird bio Inc (Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past)
Director · Feb 13, 2019 – Feb 13, 2019 · Past
Shawn Tomasello
Other companies: Cabaletta Bio, Inc. (Director · Since at least Jul 21, 2023); 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Kalaris Therapeutics, Inc. (Director · Mar 29, 2022 – Jun 6, 2024 · Past); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); UroGen Pharma Ltd. (Director · Jun 7, 2021 – Jun 7, 2021 · Past)
Director · Feb 3, 2021 – Jun 1, 2023 · Past
Neil Gibson
Other companies: Instil Bio, Inc. (Board Member · Since at least Mar 18, 2021); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Regulus Therapeutics Inc (Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past)
Director · Feb 13, 2019 – Jun 1, 2023 · Past
Morana Jovan-Embiricos
Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Jul 29, 2020); Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Sep 16, 2021 · Past)
Director · Feb 13, 2019 – Feb 19, 2019 · Past
Patrick Baeuerle
Other companies: Cullinan Therapeutics, Inc. (Chief Scientific Officer · Jan 7, 2021 – Feb 17, 2023 · Past); Harpoon Therapeutics Inc (Director · Feb 7, 2019 – May 28, 2020 · Past)
Director · Feb 13, 2019 – Dec 10, 2020 · Past
Alfonso Quintás-Cardama
Other companies: Foghorn Therapeutics Inc. (Chief Medical Officer · Since at least Sep 11, 2023)
Chief Medical Officer · Feb 13, 2019 – Jun 1, 2023 · Past
Eric Sullivan
Other companies: Bluebird bio Inc (Principal Accounting Officer · Mar 7, 2014 – Aug 3, 2017 · Past)
Chief Financial Officer · Jun 27, 2022 – Jun 1, 2023 · Past
Mayur Ian Somaiya
Other companies: NewAmsterdam Pharma Company N.V. (Chief Financial Officer · Since at least Dec 29, 2023)
Chief Financial Officer · Feb 13, 2019 – Dec 14, 2020 · Past
Priti Hegde
Other companies: Adaptimmune Therapeutics PLC (Director · Jun 1, 2023 – Jul 1, 2024 · Past)
Director · Aug 25, 2021 – Jun 1, 2023 · Past
Robert Hofmeister
Other companies: Alaunos Therapeutics, Inc. (Director · Mar 30, 2023 – Jun 6, 2024 · Past)
Chief Scientific Officer · Oct 29, 2020 – Dec 9, 2021 · Past
Rosemary Harrison
Other companies: Trillium Therapeutics Inc (See Remarks · Jan 1, 2021 – Nov 17, 2021 · Past)
Chief Business & Strategy · Jan 10, 2022 – Jun 1, 2023 · Past
Axel HoosDirector · Apr 13, 2020 – Jun 1, 2023 · Past
Peter OlagunjuChief Operating Officer · Jul 26, 2021 – Jun 1, 2023 · Past